HUMAN SERUM ALBUMIN INGREDIENT PURCHASE AND SALE AGREEMENTAlbumin Ingredient Purchase and Sale Agreement • February 14th, 2014 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 14th, 2014 Company Industry JurisdictionThis Ingredient Purchase and Sale Agreement and its Exhibits (the “Agreement”) is made by and between [/*[CONFIDENTIAL TREATMENT REQUESTED]*/] with principal offices at [/*[CONFIDENTIAL TREATMENT REQUESTED]*/] (“Supplier”), and Ampio Pharmaceuticals., a Delaware corporation with principal offices at 5445 DTC Parkway, Suite 925 Greenwood Village, CO 80111 (“Customer”), and is made effective upon the date of last signature hereto (the “Effective Date”). Supplier and Customer are collectively referred to herein as “Parties”, or individually as a “Party”.
HUMAN SERUM ALBUMIN INGREDIENT PURCHASE AND SALE AGREEMENTAlbumin Ingredient Purchase and Sale Agreement • May 23rd, 2014 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 23rd, 2014 Company Industry JurisdictionThis Ingredient Purchase and Sale Agreement and its Exhibits (the “Agreement”) is made by and between Octapharma USA, Inc., a Virginia Corporation with principal offices at 121 River Street, Suite 1201, Hoboken, NJ 07030 (“Supplier”), and Ampio Pharmaceuticals., a Delaware corporation with principal offices at 5445 DTC Parkway, Suite 925 Greenwood Village, CO 80111 (“Customer”), and is made effective upon the date of last signature hereto (the “Effective Date”). Supplier and Customer are collectively referred to herein as “Parties”, or individually as a “Party”.
AMENDMENT NO. 2 TO HUMAN SERUM ALBUMIN INGREDIENT PURCHASE AND SALE AGREEMENTAlbumin Ingredient Purchase and Sale Agreement • October 20th, 2015 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 20th, 2015 Company Industry JurisdictionThis Amendment (this “Amendment”) No. 2 to the Human Serum Albumin Ingredient Purchase and Sale Agreement is made and entered into as of October 8, 2015 by and between Octapharma USA, Inc., a Virginia corporation (“Supplier”), and Ampio Pharmaceuticals, Inc., a Delaware corporation (“Customer”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Original Agreement (as defined below).